Bio-Rad Laboratories, Inc.

BIO

$296.52

Name : Bio-Rad Laboratories, Inc.

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $8,243,729,920.00

EPSttm : 11.09

Bio-Rad Laboratories, Inc.

$296.52

4.09%

$12.65

Float Short %

6.03

Margin Of Safety %

-21

Put/Call OI Ratio

0.32

EPS Next Q Diff

0.18

EPS Last/This Y

74.92

EPS This/Next Y

0.61

Price

296.55

Target Price

311

Analyst Recom

1.88

Performance Q

17.17

Relative Volume

0.67

Beta

1.02

Ticker: BIO

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-08	BIO	290.55	0.38	0.67	476
2025-09-09	BIO	285.77	0.38	0.67	476
2025-09-10	BIO	276.91	0.38	0.67	476
2025-09-11	BIO	286.09	0.37	0.00	476
2025-09-12	BIO	279.94	0.38	1.00	473
2025-09-15	BIO	280.43	0.37	0.50	474
2025-09-16	BIO	281.31	0.37	0.00	477
2025-09-17	BIO	280.29	0.37463976945245	0	477
2025-09-18	BIO	286.23	0.38	0.00	476
2025-09-19	BIO	283.99	0.38	0.91	475
2025-09-22	BIO	283.03	0.41	999.99	138
2025-09-23	BIO	282.36	0.52	1.00	149
2025-09-24	BIO	276.32	0.52	3.00	149
2025-09-25	BIO	270.44	0.55	0.00	153
2025-09-26	BIO	271.29	0.55	0.00	153
2025-09-29	BIO	270.12	0.54	0.00	154
2025-09-30	BIO	280.35	0.54	0.00	154
2025-10-01	BIO	298.13	0.53	1.00	155
2025-10-02	BIO	294.28	0.60	0.17	166
2025-10-03	BIO	305.96	0.57	0.30	171
2025-10-06	BIO	309.36	0.57	0.00	173
2025-10-07	BIO	296.4	0.32	0.09	259
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-08	BIO	290.38	-3.3	-184.4	9.64
2025-09-09	BIO	285.89	-3.3	-191.3	9.64
2025-09-10	BIO	276.65	-3.3	-197.4	9.64
2025-09-11	BIO	285.90	-3.3	-179.0	9.64
2025-09-12	BIO	280.09	-3.3	-195.3	9.64
2025-09-15	BIO	280.61	-3.3	-188.1	9.64
2025-09-16	BIO	282.26	-3.3	-186.1	9.64
2025-09-17	BIO	280.82	-3.3	-189.6	9.64
2025-09-18	BIO	286.44	-3.3	-181.6	9.64
2025-09-19	BIO	283.80	-3.3	-190.1	9.64
2025-09-22	BIO	283.36	-3.3	-194.0	9.64
2025-09-23	BIO	282.21	-3.3	-194.6	9.64
2025-09-24	BIO	276.32	-3.3	-199.8	9.64
2025-09-25	BIO	270.41	-3.3	-201.5	9.64
2025-09-26	BIO	271.36	-3.3	-195.0	9.64
2025-09-29	BIO	270.27	-3.3	-197.1	9.64
2025-09-30	BIO	280.39	-3.9	-184.6	9.56
2025-10-01	BIO	297.71	-3.9	-179.9	9.56
2025-10-02	BIO	294.53	-3.9	-198.5	9.56
2025-10-03	BIO	305.61	-3.9	-184.1	9.56
2025-10-06	BIO	309.30	-3.9	-180.3	9.56
2025-10-07	BIO	296.55	-3.9	-201.7	9.56
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-08	BIO	-0.03	-1.01	5.46
2025-09-09	BIO	-0.03	-1.01	5.46
2025-09-10	BIO	-0.03	-1.01	5.46
2025-09-11	BIO	-0.03	-1.01	5.47
2025-09-12	BIO	-0.03	-1.01	5.47
2025-09-15	BIO	-0.03	-1.00	5.48
2025-09-16	BIO	-0.03	-1.00	5.48
2025-09-17	BIO	-0.03	-1.00	5.48
2025-09-18	BIO	-0.03	-1.00	5.48
2025-09-19	BIO	0.00	-1.00	5.48
2025-09-22	BIO	0.00	-0.79	5.48
2025-09-23	BIO	0.00	-0.79	5.48
2025-09-24	BIO	0.00	-0.79	5.48
2025-09-25	BIO	0.00	-0.79	6.04
2025-09-26	BIO	0.00	-0.79	6.04
2025-09-29	BIO	0.00	-0.93	6.03
2025-09-30	BIO	0.00	-0.93	6.03
2025-10-01	BIO	0.00	-0.93	6.03
2025-10-02	BIO	0.00	-0.93	6.03
2025-10-03	BIO	0.00	-0.93	6.03
2025-10-06	BIO	0.00	-0.43	6.03
2025-10-07	BIO	0.00	-0.43	6.03
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

2.61

Avg. EPS Est. Current Quarter

1.93

Avg. EPS Est. Next Quarter

2.79

Insider Transactions

Institutional Transactions

-0.43

Beta

1.02

Average Sales Estimate Current Quarter

651

Average Sales Estimate Next Quarter

706

Fair Value

234.99

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

64.4

Max Drawdown 5-Year %

-73.8

Target Price

311

P/E

25.27

Forward P/E

27.42

PEG

4.95

P/S

3.14

P/B

1.13

P/Free Cash Flow

21.62

EPS

11.73

Average EPS Est. Cur. Y

9.56

EPS Next Y. (Est.)

10.17

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

12.5

Relative Volume

0.67

Return on Equity vs Sector %

-20.7

Return on Equity vs Industry %

-14.2

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.09

EBIT Estimation

-201.7

Bio-Rad Laboratories, Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 7700

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, quality control process, food safety, and science education applications. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, and transfusion and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

stock quote shares BIO – Bio-Rad Laboratories, Inc. Stock Price stock today

news today BIO – Bio-Rad Laboratories, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch BIO – Bio-Rad Laboratories, Inc. yahoo finance google finance

stock history BIO – Bio-Rad Laboratories, Inc. invest stock market

stock prices BIO premarket after hours

ticker BIO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: BIO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y